MAZEMaze Therapeutics, Inc.
$27.11+18% 1Y
$27.11
$22.4052 weeks$51.83
Is the business good?
How good a business is MAZE?
- Share count, year on year
- +35%
Share count, year on year · shareholders own a smaller slice than a year ago
Details›
- Free cash flow, trailing twelve months
- −$107M
- Net income, trailing twelve months
- −$134M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry